2010
An investigation into the long-obscured mystery of dimethyltryptamine (DMT), a molecule found in nearly every living organism and considered the most potent psychedelic on Earth.
75 min
CLEAR ALL
The scientists hope their long-awaited study on LSD in humans will open the floodgates to further research into psychedelics.
1
The late chemist Albert Hofmann discussed his psychedelic research on LSD in the July, 1976 issue of High Times.
2
A small community of experimental psychotherapists—along with self-medicating users—have been using acid and mushrooms to treat mental health conditions for years, with promising results.
By the mid-1950s, LSD research was being published in medical and academic journals all over the world. It showed potential benefits in the treatment of alcoholism, drug addiction, and other mental illnesses. This film explores those potential benefits, and the researchers who explored them.
Mark Haden will explore the history and current research and possible future regulation of psychedelics. He will begin with an overview of indigenous history then explore the history in Canada and why psychedelics were criminalized.
Mark Haden is the executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada as well as an adjunct professor at the University of British Columbia School of Public and Population Health.
A renaissance is underway in the scientific study of psychedelics, both as a mode of therapy for mental illness and as a tool for understanding the mind.
New research using psychedelic drugs to understand the brain could lead to new treatments for mental disorders such as depression.
The talk will review brain imaging work on the action of psychedelics on the brain and describe the results of a clinical trial assessing psilocybin as a treatment for depression. It will also review the broader societal impact of psychedelic drug-use and discuss its implications.